GCL
COCHW icon

Glazer Capital LLC’s Envoy Medical Warrant COCHW Stock Holding History

Glazer Capital LLC’s Portfolio COCHW Stock Details COCHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,078
Closed -$13K – 695
2022
Q1 		$13K Sell
50,078
-367,635
-88% -$158K ﹤0.01% 502
2021
Q4 		$330K Buy
+417,713
New +$306K 0.01% 537

Other funds holding COCHW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Glazer Capital LLC's COCHW Position: Q2 2022 in Review

Glazer Capital LLC sold out of Envoy Medical Warrant (COCHW) in Q2 2022, closing a stake of 50,078 shares — an estimated $13K sold.

Glazer Capital LLC first reported a position in COCHW in Q4 2021 and held it in 2 quarters. The position peaked at $330K in Q4 2021. 56 funds tracked by Wall St. Rank hold COCHW as of Q2 2022.

  • Glazer Capital LLC reported no remaining Envoy Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Glazer Capital LLC sold 50,078 Envoy Medical Warrant shares in Q2 2022, an estimated $13K.
  • Glazer Capital LLC first reported a position in Envoy Medical Warrant in Q4 2021 and held it in 2 quarters.
  • Glazer Capital LLC's Envoy Medical Warrant position peaked at $330K in Q4 2021.
  • 56 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q2 2022.

Based on Glazer Capital LLC's 13F filing for Q2 2022, filed 15 Aug 2022.